(Q34852345)

4 August 2017

1 reference

title

1st class ticket to class I: protein toxins as pathfinders for antigen presentation (English)

1 reference

4 August 2017

4

Eric Tartour

0 references

Ludger Johannes

object named as

Ludger Johannes

5

0 references

author name string

Daniel C Smith

1

1 reference

4 August 2017

J Michael Lord

2

1 reference

4 August 2017

Lynne M Roberts

3

1 reference

4 August 2017

publication date

1 October 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

3

1 reference

4 August 2017

issue

10

1 reference

4 August 2017

page(s)

697-704

1 reference

Generation, translocation, and presentation of MHC class I-restricted peptides

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Antigen processing for amateurs and professionals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Development of non-live vectors and procedures (liposomes, pseudo-viral particles, toxin, beads, adjuvantsellipsis) as tools for cancer vaccines.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Roles of heat-shock proteins in antigen presentation and cross-presentation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Peptides fused to the amino-terminal end of diphtheria toxin are translocated to the cytosol

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Toxin entry: retrograde transport through the secretory pathway

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

The ER translocon and retrotranslocation: is the shift into reverse manual or automatic?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Presentation of an exogenous antigen by major histocompatibility complex class I molecules.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Immunology Inside the gearbox of the dendritic cell

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Regulation of T cell immunity by dendritic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

1 reference

7 January 2021

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

The immunologist's grail: vaccines that generate cellular immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0854.2002.31001.X

7 January 2021

10.1034/J.1600-0854.2002.31001.X

Identifiers

DOI

1 reference

4 August 2017

1 reference